HOME >> BIOLOGY >> NEWS
DNA testing identifies suspect bacteria in coral reef disease

SALT LAKE CITY Using molecular microbiology techniques, scientists are a significant step closer to understanding and identifying the deadly microbes responsible for the mysterious black band disease that is destroying the worlds coral reef ecosystems.

One of the most destructive and widespread of the coral diseases, black band disease is characterized by a ring-shaped bacterial mat that rapidly migrates across a coral colony, leaving dead tissue and bare coral skeleton in its wake.

By sequencing the entire 16S rRNA gene a genetic fingerprint found in all living organisms geologist Bruce Fouke and postdoctoral microbiologist researchers Jorge

Frias-Lopez and George Bonheyo at the University of Illinois at Urbana-Champaign have now identified the main bacteria associated with the black band bacterial mat causing the disease.

The black band microbial mat is dominated by large filamentous cyanobacteria that were previously optically identified as Phormidium corallyticum, Fouke said. Based on the gene sequence analyses, however, we have identified at least three different closely related species of cyanobacteria associated with the bacterial black band mat in different ocean basins around the world.

In earlier work, Fouke and his colleagues showed that the bacteria inhabiting the

black-band disease microbial mat were different from those found either in healthy coral tissue or in the overlaying seawater. That work, which was based upon partial sequencing of bacterial 16S rRNA genes, appeared in the May 2002 issue of Applied and Environmental Microbiology.

To make a more accurate identification of the cyanobacterium inhabiting the black band biomat, the researchers recently collected samples from infected corals on the reef tracts of Papua New Guinea in the Indo-Pacific Ocean and the Netherlands Antilles in the Caribbean Sea. Then they extracted the microbes 16S rRNA gene in their molecular geomicrobiology l
'"/>

Contact: James E. Kloeppel
kloeppel@uiuc.edu
217-244-1073
University of Illinois at Urbana-Champaign
21-May-2002


Page: 1 2 3

Related biology news :

1. Far more men than women favor routine paternity testing at birth
2. Nucleic acid-amplification testing further safeguards nations blood supply
3. Clinical judgement still counts strongly alongside genetic testing
4. Genetic testing of embryos to pick savior sibling OK with most Americans
5. Annual bioethics forum to explore genetic testing
6. New toxicity test could cut animal testing
7. Revised guidelines published for testing for hereditary type of colorectal cancer
8. Study calls for end to age thresholds for prenatal genetic testing
9. Genetic testing of embryos
10. HPV testing could be future strategy for primary screening for cervical cancer
11. High-risk women welcome genetic testing for breast cancer gene

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DNA testing identifies suspect bacteria coral reef disease

(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in the ... One major trend emerging in this market is ... is important to upgrade biometric solutions to the latest ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:1/22/2015)... The laboratory information management systems market is ... of technological advancements due to factors such as rising ... integrate healthcare systems, and increasing government support for adoption ... Key players in the market focus on technological advancements ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited ... seminar on probiotics in San Diego, CA. , The ... for health care professionals. This year’s pre-conference seminar was held ... health. Dr. Leyer spoke about the emerging topics and science ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
Cached News: